Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $810,356 - $1.19 Million
-10,206 Reduced 47.46%
11,297 $901,000
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $1.85 Million - $2.35 Million
21,372 Added 16314.5%
21,503 $2.26 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $12,911 - $15,708
131 New
131 $14,000
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $1.36 Million - $1.63 Million
-14,785 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $1.28 Million - $1.42 Million
14,785 New
14,785 $1.38 Million
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $1.33 Million - $1.68 Million
-19,888 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $1.09 Million - $1.58 Million
19,758 Added 15198.46%
19,888 $1.55 Million
Q2 2020

Aug 14, 2020

SELL
$30.2 - $56.98 $72,782 - $137,321
-2,410 Reduced 94.88%
130 $7,000
Q1 2020

May 15, 2020

BUY
$24.87 - $38.56 $37,976 - $58,881
1,527 Added 150.74%
2,540 $75,000
Q4 2019

Feb 14, 2020

BUY
$25.43 - $36.67 $25,760 - $37,146
1,013 New
1,013 $37,000
Q3 2019

Nov 14, 2019

SELL
$23.0 - $27.97 $161 - $195
-7 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $159 - $199
7 New
7 $0

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.